BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Bone Metastases
Interventions: DRUG: Radium-223 chloride (BAY88-8223)
Sponsor: Bayer